Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (437)
Cancellation by sponsor (155)
Prescription medicine registration (29)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2025 (40)
2024 (47)
2023 (36)
2022 (54)
2021 (41)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

631 result(s) found, displaying 61 to 70

AusPAR: Yonsa Mpred

8 August 2024

Australian public assessment report (AusPar)

Yonsa Mpred (abiraterone acetate + methylprednisolone) has been approved for the treatment of metastatic castration resistant prostate cancer and metastatic hormone sensitive prostate cancer.
Gemcitabine SUN gemcitabine hydrochloride 2000mg/200mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1900mg/190mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1600mg/160mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1800mg/180mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1700mg/170mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1500mg/150mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1400mg/140mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 1300mg/130mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
Gemcitabine SUN gemcitabine hydrochloride 2200mg/220mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

9 July 2024

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.